Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Adrian Farrugia, Carla Treloar & Suzanne Fraser. (2022) Overdoselifesavers.org: a mixed-method evaluation of a public information website on experiences of overdose and using take-home naloxone to save lives. Drugs: Education, Prevention and Policy 29:1, pages 43-53.
Read now
Read now
Rachel P. Winograd, Kim B. Werner, Lauren Green, Sarah Phillips, Jenny Armbruster & Robert Paul. (2020) Concerns that an opioid antidote could “make things worse”: Profiles of risk compensation beliefs using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) scale. Substance Abuse 41:2, pages 245-251.
Read now
Read now
Christopher Calabrese & Robert A. Bell. (2019) Opposition to Nonprescription Naloxone Access: Measurement and Psychosocial Predictors. Substance Use & Misuse 54:11, pages 1853-1861.
Read now
Read now
Olihe N. Okoro, Karen M. Bastianelli, Ya-Feng Wen, Elisabeth F. Bilden, Brian K. Konowalchuk & Mark E. Schneiderhan. (2018) Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone. Substance Abuse 39:1, pages 14-20.
Read now
Read now
Rachel P. Winograd, Corey S. Davis, Maria Niculete, Elizabeth Oliva & Richard P. Martielli. (2017) Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings. Substance Abuse 38:2, pages 135-140.
Read now
Read now
Jeffrey Rudski. (2016) Public Perspectives on Expanding Naloxone Access to Reverse Opioid Overdoses. Substance Use & Misuse 51:13, pages 1771-1780.
Read now
Read now
Robyn Dwyer, Suzanne Fraser & Paul Dietze. (2016) Benefits and barriers to expanding the availability of take-home naloxone in Australia: A qualitative interview study with service providers. Drugs: Education, Prevention and Policy 23:5, pages 388-396.
Read now
Read now
J. Deanna Wilson, Natalie Spicyn, Pamela Matson, Anika Alvanzo & Leonard Feldman. (2016) Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings. Substance Abuse 37:3, pages 480-487.
Read now
Read now
Shane R. Mueller, Alexander Y. Walley, Susan L. Calcaterra, Jason M. Glanz & Ingrid A. Binswanger. (2015) A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Substance Abuse 36:2, pages 240-253.
Read now
Read now
Articles from other publishers (42)
David Chavanne, Jasjit S. Ahluwalia & Kimberly Goodyear. (2023) The effects of race and class on community-level stigmatization of opioid use and policy preferences. International Journal of Drug Policy 120, pages 104147.
Crossref
Crossref
Samantha Colledge-Frisby, Kasun Rathnayake, Suzanne Nielsen, Mark Stoove, Lisa Maher, Paul A. Agius, Peter Higgs & Paul Dietze. (2023) Injection Drug Use Frequency Before and After Take-Home Naloxone Training. JAMA Network Open 6:8, pages e2327319.
Crossref
Crossref
Jacob Steenblik, Andrew Jones, Carrie Gold, Gerrit Seymour, Larry Garrett, Marina Griffith, Alejandro Blitch, Sikoti Langi, Jonathan Crump & Troy Madsen. (2023) Improving access to naloxone and opioid resources through the emergency department. The American Journal of Emergency Medicine 68, pages 201-205.
Crossref
Crossref
Erica Heiman, Sothivin Lanh, Tim P. Moran, Alaina Steck & Joseph Carpenter. (2022) Electronic Advisories Increase Naloxone Prescribing Across Health Care Settings. Journal of General Internal Medicine 38:6, pages 1402-1409.
Crossref
Crossref
Sarah Febres‐Cordero, Daniel J. Smith, Abigail Z. Wulkan, Abigail Julier Béliveau, Andy Gish, Stella Zine, Laurie Fugitt & Nicholas A. Giordano. (2022) It's what the community demands: Results of community‐based emergency opioid overdose trainings. Public Health Nursing 40:1, pages 44-53.
Crossref
Crossref
Adriane N. Irwin, Jeffrey P. Bratberg, Zain Al-jammali, Jenny Arnold, Mary Gray, Anthony S. Floyd, Derek Bolivar, Ryan Hansen, Daniel M. Hartung & Traci C. Green. (2023) Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. Journal of the American Pharmacists Association 63:1, pages 284-294.e1.
Crossref
Crossref
Ingrid A. Binswanger, Deborah Rinehart, Shane R. Mueller, Komal J. Narwaney, Melanie Stowell, Nicole Wagner, Stan Xu, Rebecca Hanratty, Josh Blum, Kevin McVaney & Jason M. Glanz. (2022) Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial. Journal of General Internal Medicine 37:11, pages 2624-2633.
Crossref
Crossref
Lauren A. Monds, Maria Bravo, Llewellyn Mills, Annie Malcolm, Rosie Gilliver, William Wood, Mary Ellen Harrod, Phillip Read, Suzanne Nielsen, Paul M. Dietze, Simon Lenton, Anne M. Bleeker & Nicholas Lintzeris. (2022)
The Overdose Response with Take Home Naloxone (
ORTHN
) project: Evaluation of health worker training, attitudes and perceptions
. Drug and Alcohol Review 41:5, pages 1085-1094.
Crossref
Crossref
Fahad Marzouq Alotaibi, Mohammed Fathullah Zaitoun, Rayid Shabeeb Alotabi, Mohammed Saeed A. Alhadi, Amani Mohammed AlShahrani, Alyah Abdullah Almoeed, Marzouq Saeed AlNasser & Ghazi Bamagous. (2022) Assessment of knowledge and awareness regarding opioid overdose and toxicity among a sample of healthcare providers. Pharmacy Education 22:1, pages 265-275.
Crossref
Crossref
Renae Fomiatti, Adrian Farrugia, Suzanne Fraser, Robyn Dwyer, Joanne Neale & John Strang. (2020) Addiction stigma and the production of impediments to take-home naloxone uptake. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 26:2, pages 139-161.
Crossref
Crossref
Wai Chung Tse, Filip Djordjevic, Viandro Borja, Louisa Picco, Tina Lam, Anna Olsen, Sarah Larney, Paul Dietze & Suzanne Nielsen. (2022) Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply. International Journal of Drug Policy 100, pages 103513.
Crossref
Crossref
Lucas Martignetti & Winnie Sun. (2022) Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review. Cureus.
Crossref
Crossref
Juan Carlos C. Montoy, Mary P. Mercer, Eric C. Silverman, Maria C. Raven & Kathy T. LeSaint. (2022) Emergency medicine services providers' attitudes toward naloxone distribution and training programs. The American Journal of Emergency Medicine 51, pages 76-78.
Crossref
Crossref
Beth A. Uzwiak, Anastasia Hudgins & Lia N. Pizzicato. (2021) Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia. International Journal of Drug Policy 97, pages 103351.
Crossref
Crossref
Cameron Dezfulian, Aaron M. Orkin, Bradley A. Maron, Jonathan Elmer, Saket Girotra, Mark T. Gladwin, Raina M. Merchant, Ashish R. Panchal, Sarah M. Perman, Monique Anderson Starks, Sean van Diepen & Eric J. Lavonas. (2021) Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association. Circulation 143:16.
Crossref
Crossref
Jerel M. Ezell, Suzan Walters, Samuel R. Friedman, Rebecca Bolinski, Wiley D. Jenkins, John Schneider, Bruce Link & Mai T. Pho. (2021) Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities. Social Science & Medicine 268, pages 113470.
Crossref
Crossref
Taylor J. Holland, Jonathan Penm, Jacinta Johnson, Maria Sarantou & Betty B. Chaar. (2020) Stakeholders’ Perceptions of Factors Influencing the Use of Take-Home-Naloxone. Pharmacy 8:4, pages 232.
Crossref
Crossref
Janine G. Martino, Shawn R. Smith, Sally Rafie, Samantha Rafie & Carla Marienfeld. (2019) Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue. The American Journal on Addictions 29:1, pages 65-72.
Crossref
Crossref
Tarlise Townsend, Freida Blostein, Tran Doan, Samantha Madson-Olson, Paige Galecki & David W. Hutton. (2020) Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. International Journal of Drug Policy 75, pages 102536.
Crossref
Crossref
Alexander C. Tsai, Mathew V. Kiang, Michael L. Barnett, Leo Beletsky, Katherine M. Keyes, Emma E. McGinty, Laramie R. Smith, Steffanie A. Strathdee, Sarah E. Wakeman & Atheendar S. Venkataramani. (2019) Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Medicine 16:11, pages e1002969.
Crossref
Crossref
Elizabeth Saunders, Stephen A. Metcalf, Olivia Walsh, Sarah K. Moore, Andrea Meier, Bethany McLeman, Samantha Auty, Sarah Bessen & Lisa A. Marsch. (2019) “You can see those concentric rings going out”: Emergency personnel’s experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire. Drug and Alcohol Dependence 204, pages 107555.
Crossref
Crossref
John Strang, Rebecca McDonald, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Alison Ritter & Ola Dale. (2019) Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Drugs 79:13, pages 1395-1418.
Crossref
Crossref
Jordan O. Smith, Scott S. Malinowski & Jordan M. Ballou. (2019) Public perceptions of naloxone use in the outpatient setting. Mental Health Clinician 9:4, pages 275-279.
Crossref
Crossref
Tess M. Kilwein, Laurel A. Wimbish, Lauren Gilbert & Rodney A. Wambeam. (2019) Practices and concerns related to naloxone use among emergency medical service providers in a rural state: A mixed-method examination. Preventive Medicine Reports 14, pages 100872.
Crossref
Crossref
Emily Behar, Rita Bagnulo & Phillip O. Coffin. (2018) Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Preventive Medicine 114, pages 79-87.
Crossref
Crossref
Jing Xu, Corey S. Davis, Marisa Cruz & Peter Lurie. (2018) State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies. Drug and Alcohol Dependence 189, pages 37-41.
Crossref
Crossref
Alyssa M. Peckham, Maria E. Niculete, Howard Steinberg & Douglas L. Boggs. (2018) A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program. Journal of Public Health Management and Practice 24:4, pages 310-317.
Crossref
Crossref
Lauren C. Haggerty, Sharon S. Gatewood & Jean-Venable “Kelly” R. Goode. (2018) Public attitudes and beliefs about Virginia community pharmacists dispensing and administering naloxone. Journal of the American Pharmacists Association 58:4, pages S73-S77.e1.
Crossref
Crossref
Sarah Cercone Heavey, Yu-Ping Chang, Bonnie M. Vest, R. Lorraine Collins, William Wieczorek & Gregory G. Homish. (2018) ‘I have it just in case’ — Naloxone access and changes in opioid use behaviours. International Journal of Drug Policy 51, pages 27-35.
Crossref
Crossref
Juliette F Spelman, Stephanie Peglow, Amy R Schwartz, Lucille Burgo-Black, Katelyn McNamara & William C Becker. (2017) Group Visits for Overdose Education and Naloxone Distribution in Primary Care: A Pilot Quality Improvement Initiative. Pain Medicine 18:12, pages 2325-2330.
Crossref
Crossref
Adrian Farrugia, Suzanne Fraser & Robyn Dwyer. (2017) Assembling the Social and Political Dimensions of Take-Home Naloxone. Contemporary Drug Problems 44:3, pages 163-175.
Crossref
Crossref
Tomás Barry, Jan Klimas, Helen Tobin, Mairead Egan & Gerard Bury. (2017) Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision. British Journal of General Practice 67:657, pages e267-e273.
Crossref
Crossref
Traci C. Green, Patricia Case, Haley Fiske, Janette Baird, Shachan Cabral, Dina Burstein, Victoriana Schwartz, Nathan Potter, Alexander Y. Walley & Jeffrey Bratberg. (2017) Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. Journal of the American Pharmacists Association 57:2, pages S19-S27.e4.
Crossref
Crossref
Mark Bounthavong, Michael A. Harvey, Daina L. Wells, Sarah J. Popish, Julianne Himstreet, Elizabeth M. Oliva, Chad L. Kay, Marcos K. Lau, Priyanka P. Randeria-Noor, Andrea G. Phillips & Melissa L.D. Christopher. (2017) Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis. Journal of the American Pharmacists Association 57:2, pages S68-S72.
Crossref
Crossref
Mari-Lynn Drainoni, Elisa A. Koppelman, James A. Feldman, Alexander Y. Walley, Patricia M. Mitchell, Jacqueline Ellison & Edward Bernstein. (2016) Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment. BMC Research Notes 9:1.
Crossref
Crossref
Christopher Robert Keane. (2016) Resilience, tipping, and hydra effects in public health: emergent collective behavior in two agent-based models. BMC Public Health 16:1.
Crossref
Crossref
Harshal Kirane, Michael Ketteringham, Sewit Bereket, Richie Dima, Ann Basta, Sonia Mendoza & Helena Hansen. (2016) Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention. Journal of Substance Abuse Treatment 69, pages 44-49.
Crossref
Crossref
Amanda K. Gatewood, Michael J. Van Wert, Andrew P. Andrada & Pamela J. Surkan. (2016) Academic physicians' and medical students' perceived barriers toward bystander administered naloxone as an overdose prevention strategy. Addictive Behaviors 61, pages 40-46.
Crossref
Crossref
David C. Lott & Jonathan Rhodes. (2016) Opioid overdose and naloxone education in a substance use disorder treatment program. The American Journal on Addictions 25:3, pages 221-226.
Crossref
Crossref
Traci C. Green, Emily F Dauria, Jeffrey Bratberg, Corey S. Davis & Alexander Y Walley. (2015) Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm Reduction Journal 12:1.
Crossref
Crossref
Karla D. Wagner, Lin Liu, Peter J. Davidson, Jazmine Cuevas-Mota, Richard F. Armenta & Richard S. Garfein. (2015) Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention. Drug and Alcohol Dependence 153, pages 215-220.
Crossref
Crossref
Richard J. Bodnar. (2014) Endogenous opiates and behavior: 2013. Peptides 62, pages 67-136.
Crossref
Crossref